Medindia LOGIN REGISTER
Medindia

Abacavir, Dolutegravir and Lamivudine - Indications, Dosage, Side Effects and Precautions

Advertisement

Abacavir, Dolutegravir and Lamivudine Medication Information

Discover comprehensive details about Abacavir, Dolutegravir and Lamivudine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Abacavir, Dolutegravir and Lamivudine brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Abacavir, Dolutegravir and Lamivudine
Pronunciation :  (a bak' a vir), (doe" loo teg' ra vir) and (la miv' ue deen)

Brand Names or Trade Names of Abacavir, Dolutegravir and Lamivudine

India :


Inbec

International :


Triumeq®, Triumeq PD®

Overview of Abacavir, Dolutegravir and Lamivudine

Abacavir and lamivudine belong to the class of medications called nucleoside reverse transcriptase inhibitors (NRTIs), while dolutegravir is in a class of medications known as HIV Integrase inhibitors. These drugs function by lowering HIV levels in the patient’s blood.

Why is Abacavir, Dolutegravir and Lamivudine Prescribed? (Indications)

Abacavir, Dolutegravir,and Lamivudine combination tablets are prescribed to HIV-infected patients.
Although it is not a cure for HIV, it boosts the immune system and helps prevent AIDS and other HIV complications. 

When should Abacavir, Dolutegravir and Lamivudine not be taken? (Contraindications)

  • Contraindicated in patients with known allergies to Abacavir, Dolutegravir and Lamivudine.

  • Abacavir, Dolutegravir and Lamivudine may interact with other medications. Consult with your doctor to avoid any interaction related side effects.

  • Contraindicated in patients with a history of liver disease, heart disease, or kidney disease.

  • If you are pregnant or breastfeeding, avoid taking this medication.

  • This medication is not recommended for children younger than 3 months and less than 6kg in body weight.

How should Abacavir, Dolutegravir and Lamivudine be taken?

Take Abacavir, Dolutegravir, and Lamivudine tablets orally with or without food.
Do not break or chew the tablet; swallow it as a whole.
For tablets for suspension, follow the instructions on their label.

Missed a Dose?

If you miss a dose, it is better to skip and take the next dose correctly. Do not double the dose.

What are the warnings and precautions for Abacavir, Dolutegravir and Lamivudine?

#8226;If you are pregnant and breastfeeding, consult your doctor before taking the medication.

Discuss with your doctor about all your current medication or herbal product history to avoid drug interactions.

If you notice allergic symptoms or any other unusual symptom, consult with your doctor immediately.

Avoid alcohol consumption or smoking as it may interfere with the medication.

What are the side effects of Abacavir, Dolutegravir and Lamivudine?

  • Headache, Dizziness, Nausea and Vomiting
  • Signs of infection (such as fever, chills, swollen lymph nodes, trouble breathing, cough, non-healing skin sores)
  • Vision changes
  • Lactic acidosis
  • Liver problems
  • Changes in immune system
  • Heart attack

What are the other precautions for Abacavir, Dolutegravir and Lamivudine?

In the event of an overdose, visit your doctor immediately.

What are the Drug Interactions of Abacavir, Dolutegravir and Lamivudine?

Avoid taking Abacavir, Dolutegravir and Lamivudine medication along with Dofetilide (Tikosyn), Orlistat, and sorbitol tablets.
Avoid taking herbal products such as St. John’s wort while taking Abacavir, Dolutegravir and Lamivudine tablets.

What are the storage conditions for Abacavir, Dolutegravir and Lamivudine?

Store at room temperature between 20 and 25°C.
Store in a tightly closed container away from heat and moisture.
Keep them out of the reach of children.

Advertisement
Recommended Reading

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional